Certuity LLC Makes New $242,000 Investment in Colgate-Palmolive (NYSE:CL)

Certuity LLC acquired a new stake in shares of Colgate-Palmolive (NYSE:CL) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 3,032 shares of the company’s stock, valued at approximately $242,000.

Several other large investors have also recently made changes to their positions in the company. Dakota Wealth Management boosted its stake in Colgate-Palmolive by 73.3% during the third quarter. Dakota Wealth Management now owns 8,573 shares of the company’s stock worth $610,000 after buying an additional 3,627 shares during the period. FinTrust Capital Advisors LLC boosted its position in Colgate-Palmolive by 46.2% during the third quarter. FinTrust Capital Advisors LLC now owns 5,140 shares of the company’s stock valued at $366,000 after purchasing an additional 1,625 shares in the last quarter. Raymond James & Associates grew its position in shares of Colgate-Palmolive by 1.2% in the 3rd quarter. Raymond James & Associates now owns 900,300 shares of the company’s stock worth $64,020,000 after buying an additional 10,446 shares during the last quarter. Stratos Wealth Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 6.1% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 9,201 shares of the company’s stock valued at $654,000 after purchasing an additional 529 shares during the last quarter. Finally, HTG Investment Advisors Inc. grew its stake in Colgate-Palmolive by 1.9% during the 3rd quarter. HTG Investment Advisors Inc. now owns 8,152 shares of the company’s stock worth $580,000 after buying an additional 152 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 0.0 %

Shares of NYSE:CL opened at $91.90 on Thursday. The business has a 50-day moving average price of $88.08 and a 200 day moving average price of $81.99. The company has a market capitalization of $75.40 billion, a price-to-earnings ratio of 29.08, a PEG ratio of 3.39 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $92.54. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.73 EPS. Sell-side analysts expect that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.18%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of Colgate-Palmolive stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the transaction, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders sold 159,048 shares of company stock worth $13,336,846 in the last 90 days. Corporate insiders own 0.34% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. Stifel Nicolaus upped their target price on Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research report on Monday. Citigroup boosted their price target on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Finally, Bank of America upped their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.